Rare diseases
Investigational molecules
Locations
Back to Hungary1 052 clinical trials in Budapest, Hungary across 10 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Long‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
HungaryStudy of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis
HungaryProphylactic Tocilizumab to Prevent Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma Patients Receiving JNJ-79635322 and Human Normal Immunoglobulin (IV)
HungaryPhase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)
HungaryA Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
HungaryEfficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration
HungarySafety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease
HungaryPhase 3 Study of Romiplostim Combined with Prednisolone versus Prednisolone Alone in Adults with Previously Untreated Primary Immune Thrombocytopenia (ITP)
HungaryEfficacy and Safety of BAY 3670549 in Adults with Atrial Fibrillation: A Randomized, Double‑Blind, Placebo‑Controlled Phase 2 Study
HungaryPhase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis
HungaryEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
HungaryA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
HungaryThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for inflammatory disorders, including studies on new therapies for psoriasis, psoriatic arthritis, and chronic urticaria.
Multiple clinical trials are investigating targeted therapies and their long-term effectiveness in managing inflammatory conditions.
Studies centered on preventing and treating various infections, with particular emphasis on meningococcal vaccines and respiratory conditions.
Research includes both preventive vaccines and therapeutic approaches for various infectious diseases.
Comprehensive research into heart failure prevention and management of chronic conditions, including studies on kidney disease and obesity.
Investigations focus on innovative therapeutic combinations and their impact on cardiovascular outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
